These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transcriptomic insights into multiple system atrophy from a PLP-α-synuclein transgenic mouse model. Nicholson L; Piras IS; DeBoth MD; Siniard A; Heras-Garvin A; Stefanova N; Huentelman MJ Brain Res; 2024 Jul; 1834():148912. PubMed ID: 38575106 [TBL] [Abstract][Full Text] [Related]
6. Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1. Jellinger KA J Alzheimers Dis; 2018; 62(3):1141-1179. PubMed ID: 28984582 [TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE. Chaudhary P; Marracci GH; Calkins E; Pocius E; Bensen AL; Scanlan TS; Emery B; Bourdette DN J Neuroimmunol; 2021 Mar; 352():577468. PubMed ID: 33422763 [TBL] [Abstract][Full Text] [Related]
8. Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy. Mészáros L; Hoffmann A; Wihan J; Winkler J Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316335 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy. Woerman AL; Patel S; Kazmi SA; Oehler A; Lee J; Mordes DA; Olson SH; Prusiner SB PLoS Pathog; 2020 Feb; 16(2):e1008222. PubMed ID: 32017806 [TBL] [Abstract][Full Text] [Related]
10. The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy. Abdul-Rahman T; Herrera-Calderón RE; Ahluwalia A; Wireko AA; Ferreira T; Tan JK; Wolfson M; Ghosh S; Horbas V; Garg V; Perveen A; Papadakis M; Ashraf GM; Alexiou A CNS Neurosci Ther; 2024 Apr; 30(4):e14678. PubMed ID: 38572788 [TBL] [Abstract][Full Text] [Related]
11. Understanding the Role of CDH4 in Multiple System Atrophy Brain. Isik FI; Katzeff JS; Fu Y; Kim WS J Parkinsons Dis; 2023; 13(8):1303-1311. PubMed ID: 38143373 [TBL] [Abstract][Full Text] [Related]
12. Multiple system atrophy and apolipoprotein E. Ogaki K; Martens YA; Heckman MG; Koga S; Labbé C; Lorenzo-Betancor O; Wernick AI; Walton RL; Soto AI; Vargas ER; Nielsen HM; Fujioka S; Kanekiyo T; Uitti RJ; van Gerpen JA; Cheshire WP; Wszolek ZK; Low PA; Singer W; Dickson DW; Bu G; Ross OA Mov Disord; 2018 Apr; 33(4):647-650. PubMed ID: 29442376 [TBL] [Abstract][Full Text] [Related]
13. Tissue resident memory CD8+ T cells are present but not critical for demyelination and neurodegeneration in a mouse model of multiple system atrophy. Corbin-Stein NJ; Childers GM; Webster JM; Zane A; Yang YT; Ali MA; Sandoval IM; Manfredsson FP; Kordower JH; Tyrrell DJ; Harms AS bioRxiv; 2024 Jun; ():. PubMed ID: 38895456 [TBL] [Abstract][Full Text] [Related]
14. Distinct Parameters in the EEG of the PLP α-SYN Mouse Model for Multiple System Atrophy Reinforce Face Validity. Härtner L; Keil TW; Kreuzer M; Fritz EM; Wenning GK; Stefanova N; Fenzl T Front Behav Neurosci; 2016; 10():252. PubMed ID: 28119583 [TBL] [Abstract][Full Text] [Related]
15. Erratum to "NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice". Anandhan A; Nguyen N; Syal A; Dreher LA; Dodson M; Zhang DD; Madhavan L Aging Dis; 2024 May; 15(3):951-952. PubMed ID: 37728584 [No Abstract] [Full Text] [Related]
16. Sobetirome rescues α-synuclein-mediated demyelination in an in vitro model of multiple system atrophy. Mészáros L; Himmler M; Schneider Y; Arnold P; Dörje F; Schubert DW; Winkler J Eur J Neurosci; 2024 Jan; 59(2):308-315. PubMed ID: 38086536 [TBL] [Abstract][Full Text] [Related]